| Company Name: | Gentiva Health Services, Inc. | | Ticker Symbol: | GTIV | | | WWW Address: | www.gentiva.com | | CEO: | H. Anthony (Tony) Strange | | No. of Employees: | 4,300 | | Common Issue Type: | CS | | Business Description: | The Company provides comprehensive home health services throughout most of the United States.
|
| | | Industry Information: | HEALTH SERVICES - Home Health Care [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 24.43 |  0.18 | 24.43 | 24.45 | 24.42 | 24.56 | 23.90 | 113445 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 715.8 | 29.3 | 0.72 | 5.21 | 0.00 | 11.5 | 0.0 | 29.99 - 12.94 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 24.25 | $ | | PE Ratio - LTM | 11.5 | |
| Market Capitalisation | 710.8 | mil |
| Latest Shares Outstanding | 29.3 | mil |
| Earnings pS (EPS) | 5.21 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 302,427 | $ |
| Effective Tax Rate | 16.1 | % |
| Float | 27.0 | mil |
| Float as % of Shares Outstanding | 92.7 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 42.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 53.7 | % |
| EBITDA Margin | 10.9 | % |
| Pre-Tax Profit Margin | 8.7 | % |
| Assets Turnover | 1.2 | % |
| Return on Assets (ROA) | 6.1 | % |
| Return on Equity (ROE) | 11.4 | % |
| Return on Capital Invested (ROCI) | 8.0 | % |
| Current Ratio | 2.2 | |
| Leverage Ratio (Assets/Equity) | 1.9 | |
| Interest Cover | 9.9 | |
| Total Debt/Equity (Gearing Ratio) | 0.43 | |
| LT Debt/Total Capital | 30.0 | % |
| Working Capital pS | 6.07 | $ |
| Cash pS | 4.10 | $ |
| Book-Value pS | 18.98 | $ |
| Tangible Book-Value pS | -0.29 | $ |
| Cash Flow pS | 3.01 | $ |
| Free Cash Flow pS | 2.16 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.28 | |
| Price/Tangible Book Ratio | -82.34 | |
| Price/Cash Flow | 8.1 | |
| Price/Free Cash Flow | 11.2 | |
| P/E as % of Industry Group | 41.0 | % |
| P/E as % of Sector Segment | 78.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.0 | 102 | 2,016 | 8,841 |
| 4 Weeks | 26.63 | 23.10 | 26.14 | -7.2 | 92 | 2,510 | 50,192 |
| 13 Weeks | 27.30 | 19.88 | 21.89 | 10.8 | 104 | 2,394 | 153,225 |
| 26 Weeks | 27.30 | 14.50 | 16.02 | 51.4 | 123 | 2,639 | 335,191 |
| 52 Weeks | 29.99 | 12.94 | 23.10 | 5.0 | 77 | 3,802 | 954,212 |
| YTD | 29.99 | 12.94 | - | -17.1 | 69 | 3,908 | 879,385 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 24.18 | 24.07 | 24.91 | 20.50 | 19.83 | 0.72 | 0.70 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 9.06 | 78.4 | 3.54 |
| Income | 24.09 | 33.6 | 58.21 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -12.28 | NA | -64.14 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -13.3 | -15.0 | 5.8 |
| Earnings % | -64.1 | -87.3 | 367.4 |
| EPS % | -64.6 | -87.2 | 353.0 |
| EPS $ | -3.10 | -3.55 | 4.06 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 12.88 |
| Current Ratio | 1.9 |
| Quick Ratio (Acid Test) | 1.7 |
| Liquidity Ratio (Cash) | 0.47 |
| Receivables Turnover | 6.8 |
| Average Collection Period | 53 |
| Working Capital/Equity | 25.3 |
| Working Capital pS | 4.34 |
| Cash-Flow pS | 6.14 |
| Free Cash-Flow pS | 2.39 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.25 |
| Financial Leverage Ratio (Assets/Equity) | 2.0 |
| Debt Ratio | 49.2 |
| Total Debt/Equity (Gearing Ratio) | 0.51 |
| LT Debt/Equity | 0.51 |
| LT Debt/Capital Invested | 44.6 |
| LT Debt/Total Liabilities | 52.5 |
| Interest Cover | 10.4 |
| Interest/Capital Invested | 2.34 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 5.59 |
| Tobin's Q Ratio | 0.73 |
| Current P/E Ratio - LTM | 11.50 |
| Enterprise Value (EV)/EBITDA | 9.67 |
| Enterprise Value (EV)/Free Cash Flow | 28.10 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -82.34 |
| Price/Book Ratio - LTM | 1.28 |
| Price/Cash Flow Ratio | 8.1 |
| Price/Free Cash Flow Ratio - LTM | 11.2 |
| Price/Sales Ratio | 0.61 |
| P/E Ratio (1 month ago) - LTM | 12.6 |
| P/E Ratio (26 weeks ago) - LTM | 2.9 |
| P/E Ratio (52 weeks ago) - LTM | 4.6 |
| 5-Y High P/E Ratio | 26.2 |
| 5-Y Low P/E Ratio | 3.3 |
| 5-Y Average P/E Ratio | 15.9 |
| Current P/E Ratio as % of 5-Y Average P/E | 72 |
| P/E as % of Industry Group | 41.0 |
| P/E as % of Sector Segment | 78.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 8.70 |
| Current Liabilities pS | 5.06 |
| Tangible Book Value pS - LTM | -0.29 |
| Book Value pS - LTM | 18.98 |
| Capital Invested pS | 25.45 |
| Cash pS - LTM | 4.10 |
| Cash Flow pS - LTM | 3.01 |
| Free Cash Flow pS - LTM | 2.16 |
| Earnings pS (EPS) | 5.21 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 5.32 |
| Free Cash Flow Margin 5YEAR AVG | -1.20 |
| Net Profit Margin | 11.8 |
| Net Profit Margin - 5YEAR AVRG. | 4.8 |
| Equity Productivity | 2.63 |
| Return on Equity (ROE) | 31.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 17.8 |
| Capital Invested Productivity | 1.74 |
| Return on Capital Invested (ROCI) | 20.6 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 10.9 |
| Assets Productivity | 1.40 |
| Return on Assets (ROA) | 15.8 |
| Return on Assets (ROA) - 5YEAR AVRG. | 7.7 |
| Gross Profit Margin | 53.7 |
| Gross Profit Margin - 5YEAR AVRG. | 42.6 |
| EBITDA Margin - LTM | 10.9 |
| EBIT Margin - LTM | 9.6 |
| Pre-Tax Profit Margin | 14.1 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 6.4 |
| Effective Tax Rate | 16.1 |
| Effective Tax Rate - 5YEAR AVRG. | 30.8 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 49 |
| Revenue per Employee | 302,427 |
| Net Income per Employee | 35,686 |
| Average Collection Period | 49 |
| Receivables Turnover | 6.8 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 0.62 |
| Assets/Revenue | 0.71 |
| Net Working Capital Turnover | 10.37 |
| Fixed Assets Turnover | 1.85 |
| Total Assets Turnover | 1.4 |
| Revenue per $ Cash | 18.79 |
| Revenue per $ Plant | 20.38 |
| Revenue per $ Common Equity | 2.63 |
| Revenue per $ Capital Invested | 1.74 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 37.7 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 35.7 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |